Keel Infrastructure Corp. KEEL 深 沪
等待开盘 05-12 09:30:00 美东时间
4.30
+0.330
+8.31%
华盛通- 最 高4.50
- 今 开3.58
- 成交量 6183.61万股
- 最 低 3.56
- 昨 收 3.97
- 总市值 25.92亿
- 52周最高 6.60
- 市盈率 静 --
- 换手率 10.26%
- 52周最低 0.70
- 委 比 19.70%
- 总股本 6.03亿
- 历史最高 9.36
- 量 比 1.62
- 振 幅 23.68%
- 历史最低 0.376
- 每 手 1
- 风险率 1.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
22分钟前
Keel Shares Under Pressure After Double Miss
Keel Infrastructure Corp. (NASDAQ: KEEL) shares are trading lower Monday after the company reported first-quarter financial results.
05-11 21:09
Earnings Scheduled For May 11, 2026
Companies Reporting Before The Bell • United Parks & Resorts (NYSE:PRKS) is...
05-11 19:11
Earnings Scheduled For May 11, 2026
Companies Reporting Before The Bell • United Parks & Resorts (NYSE:PRKS) is...
05-11 19:11
Keel Infrastructure Q1 EPS $(0.21) Misses $(0.09) Estimate, Sales $37.000M Miss $37.834M Estimate
Keel Infrastructure (NASDAQ:KEEL) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.09) by 162.5 percent. This is a 200 percent decrease over losses of $(0.07) per share
05-11 19:09
期权扫描 | 盘中创新高！苹果看涨期权占比冲向80%；最高飙涨900%，高通期权爆量看涨占比75%
盘中创新高！苹果看涨期权占比冲向80%；最高飙涨900%，高通期权爆量看涨占比75%；绩后股价拉升30%，奇景光电获资金押注冲上20美元>>
05-08 19:34
Shares of companies within the broader tech sector are trading higher amid overall market strength as investors react to reports suggesting that the U.S. and Iran are nearing an agreement to end the Middle East conflict. The sector may be rallying alongside Advanced Micro Devices after the company reported strong Q1 financial results.
Shares of companies within the broader tech sector are trading higher amid over...
05-07 03:58
美股大行评级 | 美银大幅上调西部数据、希捷科技目标价！宝洁、Baker Hughes、Flagstar Bank、斯伦贝谢等获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从48美元升至49美元；Chardan Capital：维持Intellia Therapeutics"买入"评级，目标价从27美元升至30美元
04-28 10:07
Chardan Capital Initiates Coverage On Keel Infrastructure with Buy Rating, Announces Price Target of $4.5
Chardan Capital analyst Bill Papanastasiou initiates coverage on Keel Infrastructure (NASDAQ:KEEL) with a Buy rating and announces Price Target of $4.5.
04-27 21:01
Avanos Medical, Travere Therapeutics, Globalstar And Other Big Stocks Moving Higher On Tuesday
Dow Jones up 200 points, Avanos Medical Inc rose on going-private deal. Big gainers include AVNS, TVTX, BE, IONQ, SANA, RGTI, VACH, AOSL.
04-14 22:16
